TICKERNERD
Menu
VREXVREXHealthcare · Medical Devices

VREX Stock Forecast: Varex Imaging Corp. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$19
+0.11% on the day

The 5 Wall Street analysts covering Varex Imaging Corp. hold a median 12-month price target of $19 — +2.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 80 of 100 as at 22 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$780.2M
Ticker Nerd rank
80 / 100
Median analyst target
$19
Analysts covering
5
Total return, dividends reinvested
1W
+0.1%
1M
+72.7%
YTD
+58.9%
1Y
+63.2%
From 52W high
−0.4%
From 52W low
+98.6%
$9
$19
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

VREX stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Varex Imaging Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
80 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
92
Growth
91
Value
79
Issuance
74
Quality
70
Revisions
54
Size
48
Accruals
28
Volatility
14

Momentum (92): The shares have been drifting up relative to others.

Volatility (14): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

VREX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on VREX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$12$14$16$18$20Oct 25Jan 26Apr 26Jul 26VREXHigh $19Median $19Low $19

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says5 analysts
0 Buy5 Hold0 Sell
Low $19Median $19High $19

The green dot is the last close — the median target sits +2.1% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
17 Aug 2026CJS SecuritiesDowngradeMarket Perform—
11 Aug 2026OppenheimerDowngradePerform—
10 Aug 2026Sidoti & Co.DowngradeNeutral$19
19 Nov 2025B. Riley SecuritiesReiteratesBuy—
19 Nov 2025B. Riley SecuritiesReiteratesBuy$16
19 Nov 2025OppenheimerMaintainsOutperform$23 → $18
19 Nov 2025OppenheimerMaintainsOutperform—
8 Aug 2025B. Riley SecuritiesMaintainsBuy—
7 Feb 2025B. Riley SecuritiesReiteratesBuy—
7 Feb 2025OppenheimerMaintainsOutperform—
23 Aug 2024B. Riley SecuritiesInitiatesBuy—
15 Nov 2023OppenheimerMaintainsOutperform—
2 Aug 2023OppenheimerReiteratesOutperform—
24 May 2023JefferiesMaintainsHold—
12 Oct 2022JefferiesInitiatesHold—
5 Feb 2021OppenheimerUpgradeOutperform—
13 Aug 2020OppenheimerDowngradePerform—
13 May 2020JefferiesMaintainsHold—
13 May 2020JP MorganDowngradeNeutral—
13 May 2020Sidoti & Co.MaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. VREX appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

VREX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+11.5%
Analysts raising
2
Analysts cutting
1
Fundamentals

Varex Imaging Corp. (VREX) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
34.9×

Cheaper than 23% of US stocks

Price / sales
0.9×

Cheaper than 72% of US stocks

Price / book
1.6×

Cheaper than 53% of US stocks

EV / EBITDA
10.8×

Cheaper than 36% of US stocks

Growth & margins
Revenue growth (YoY)
3.7%

Higher than 36% of US stocks

Earnings growth (YoY)
—
Gross margin
33.6%

Higher than 40% of US stocks

Operating margin
10.8%

Higher than 65% of US stocks

Net margin
2.6%

Higher than 53% of US stocks

Returns & dividend
Return on equity
4.6%

Higher than 53% of US stocks

Return on assets
4.2%

Higher than 72% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

VREX vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
VREXVarex Imaging Corp.$780.2M
80
AHCOAdaptHealth Corp.$765.2M
51
BBNXBeta Bionics, Inc.$838.7M
36
INMDInMode Ltd.$865.7M
76
SSIISS Innovations International, Inc.$694.1M
17
SIBNSI-BONE, Inc.$881.5M
72
CBLLCeribell, Inc.$897.7M
32

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Varex Imaging Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest VREX news & analysis

Varex Imaging Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Varex Imaging Corporation - VREX

Business Wire · 11 Aug 2026negative

Kahn Swick & Foti, LLC (KSF) has announced an investigation into the proposed acquisition of Varex Imaging by Teledyne Technologies, under which Varex shareholders would receive $18.90 in cash per share. KSF is examining whether this consideration and the transaction process are adequate.

Why it matters — VREX shareholders may be affected by the investigation's findings regarding whether the proposed $18.90-per-share deal consideration is fair and the process was adequate.

Teledyne: Varex Acquisition Strengthens The Buy Case

Seeking Alpha · 11 Aug 2026neutral

Teledyne Technologies agreed to acquire Varex Imaging for $1.1 billion, or $18.90 per share, broadening Teledyne's healthcare equipment portfolio and X-ray capabilities.

Why it matters — Varex shareholders will receive $18.90 per share in the acquisition, marking the company's exit as an independent entity.

VAREX IMAGING (VREX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research · 10 Aug 2026neutral

Zacks published an article covering Varex Imaging Corp.'s (VREX) fiscal third-quarter earnings for the period ended June 2026. It focuses on how the company's revenue and EPS, as well as other key metrics, compare with Wall Street estimates and year-ago figures.

Why it matters — VREX watchers would care because the article highlights how the company's quarterly performance measures up against analyst expectations and the prior-year period.

VREX Stock Alert: Halper Sadeh LLC is Investigating Whether Varex Imaging Corporation is Obtaining a Fair Price for its Shareholders

Business Wire · 10 Aug 2026negative

Halper Sadeh LLC, an investor-rights law firm, announced it is investigating the sale of Varex Imaging Corporation to Teledyne Technologies Incorporated for $18.90 per share in cash. The investigation concerns whether Varex and its board are obtaining a fair price for shareholders.

Why it matters — A law-firm investigation into the fairness of the acquisition price introduces legal scrutiny around Varex's pending sale, which shareholders would want to monitor.

Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Higher On Monday

Benzinga · 10 Aug 2026positive

The news item reports that Varex Imaging posted upbeat fiscal third-quarter earnings and was among big stocks moving higher on Monday, while U.S. stocks were mixed with the Dow Jones index falling around 100 points.

Why it matters — VREX watchers would note that the company's upbeat quarterly results lifted its shares higher on a mixed trading day for the broader market.

FAQ

Frequently asked questions about VREX stock

What is the VREX stock price forecast for 2026-2027?

The 5 Wall Street analysts covering Varex Imaging Corp. have a median 12-month price target of $19, with estimates ranging from $19 to $19. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is VREX stock a buy right now?

Of the 5 analysts covering Varex Imaging Corp., 0 rate it a Buy, 5 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Varex Imaging Corp. 80 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank VREX?

As at 22 Aug 2026, Varex Imaging Corp. ranks 80 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (92 of 100).

Will VREX stock go up?

No one can know that. What the data says: the median 12-month target from 5 analysts implies +2.1% from the last close, and Ticker Nerd's factor model ranks Varex Imaging Corp. 80 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the VREX stock forecast for 2030?

No analyst covering Varex Imaging Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for VREX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $19 to $19 over the next 12 months.

How has VREX stock performed over the past year?

Varex Imaging Corp. returned +63.2% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Varex Imaging Corp. do?

Varex Imaging Corporation is a prominent company in the manufacturing and development of X-ray imaging components and solutions. Serving both medical and industrial sectors, Varex provides critical components like X-ray tubes, linear accelerators, and digital detectors which are integral to diagnostic imaging systems.

What is the latest news on VREX?

The most recent item we track (Business Wire, 11 Aug 2026): "Varex Imaging Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Varex Imaging Corporation - VREX". Kahn Swick & Foti, LLC (KSF) has announced an investigation into the proposed acquisition of Varex Imaging by Teledyne Technologies, under which Varex shareholders would receive $18.90 in cash per share. KSF is examining whether this consideration and the transaction process are adequate.

Company

About Varex Imaging Corp.

Varex Imaging Corporation is a prominent company in the manufacturing and development of X-ray imaging components and solutions. Serving both medical and industrial sectors, Varex provides critical components like X-ray tubes, linear accelerators, and digital detectors which are integral to diagnostic imaging systems. These components are essential in medical diagnostics, providing high-resolution imaging for better patient care and efficient treatment planning. Beyond healthcare, Varex’s technologies are utilized in non-destructive testing, security inspection, and industrial quality control to ensure precision and safety. Established from a legacy of innovation, Varex Imaging leverages advanced research and development to maintain its position as a leading supplier in the global market. The company is pivotal in improving the performance and reliability of imaging systems, thereby enhancing the capabilities of original equipment manufacturers (OEMs) and healthcare providers. Its contributions are significant in the ongoing advancements in medical technology and industrial inspection, underscoring the company's role as a critical player in both preventive healthcare and safety engineering. Varex Imaging's expertise and broad application range underscore its market significance, making it a key entity in the imaging solutions industry.

CEO Mr. Sunny S. Sanyal · 2,500 employees · United States · https://www.vareximaging.com